@article{6e9434f79178486bbd439457205aa9cf,
title = "Mutations in the vesicular trafficking protein Annexin A11 are associated with amyotrophic lateral sclerosis Bradley N. Smith",
abstract = "Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder. We screened 751 familial ALS patient whole-exome sequences and identified six mutations including p.D40G in the ANXA11 gene in 13 individuals. The p.D40G mutation was absent from 70,000 control whole-exome sequences. This mutation segregated with disease in two kindreds and was present in another two unrelated cases (P = 0.0102), and all mutation carriers shared a common founder haplotype. Annexin A11-positive protein aggregates were abundant in spinal cord motor neurons and hippocampal neuronal axons in an ALS patient carrying the p.D40G mutation. Transfected human embryonic kidney cells expressing ANXA11 with the p.D40G mutation and other N-terminal mutations showed altered binding to calcyclin, and the p.R235Q mutant protein formed insoluble aggregates. We conclude that mutations in ANXA11 are associated with ALS and implicate defective intracellular protein trafficking in disease pathogenesis. 2017",
keywords = "Amyotrophic Lateral Sclerosis/genetics, Annexins/genetics, Human Embryonic Stem Cells/metabolism, Humans, Mutation/genetics, Protein Binding, Protein Transport, S100 Calcium Binding Protein A6/metabolism",
author = "Smith, \{Bradley N\} and Topp, \{Simon D\} and Claudia Fallini and Hideki Shibata and Han-Jou Chen and Claire Troakes and Andrew King and Nicola Ticozzi and Kenna, \{Kevin P\} and Athina Soragia-Gkazi and Miller, \{Jack W\} and Akane Sato and Dias, \{Diana Marques\} and Maryangel Jeon and Caroline Vance and Wong, \{Chun Hao\} and \{de Majo\}, Martina and Wejdan Kattuah and Mitchell, \{Jacqueline C\} and Scotter, \{Emma L\} and Parkin, \{Nicholas W\} and Sapp, \{Peter C\} and Matthew Nolan and Nestor, \{Peter J\} and Michael Simpson and Michael Weale and Monkel Lek and Frank Baas and \{Vianney de Jong\}, \{J M\} and \{Ten Asbroek\}, \{Anneloor L M A\} and Redondo, \{Alberto Garcia\} and Jes{\'u}s Esteban-P{\'e}rez and Cinzia Tiloca and Federico Verde and Stefano Duga and Nigel Leigh and Hardev Pall and Morrison, \{Karen E\} and Ammar Al-Chalabi and Shaw, \{Pamela J\} and Janine Kirby and Turner, \{Martin R\} and Kevin Talbot and Orla Hardiman and Glass, \{Jonathan D\} and \{De Belleroche\}, Jacqueline and Masatoshi Maki and Moss, \{Stephen E\} and Christopher Miller and Cinzia Gellera",
note = "Funding Information: This work was provided by the Middlemass family, Heaton-Ellis Trust, Motor Neurone Disease Association, Medical Research Council, The Psychiatry Research Trust of the Institute of Psychiatry, Guy's and St. Thomas' Charity, the Wellcome Trust, and the Noreen Murray Foundation. This work was supported by the UK Dementia Research Institute which is funded by the Medical Research Council, Alzheimer's Society and Alzheimer's Research UK. This is a European Union Joint Programme Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organizations under the aegis of JPND (www.jpnd.eu): U.K. Medical Research Council and Economic and Social Research Council. This project is funded by the Medical Research Foundation (MRF) with salary provided for B.N.S. (MRF-060-0003-RG-SMITH). C.E.S. and A.A.-C. received salary support from the National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London and Maudsley National Health Service (NHS) Foundation Trust and King's College London. C.F. received salary support from the ALS Association (ALSA). H.S. and M.M. were supported by the Japan Society for the Promotion of Science grants (15K07384 to H.S. and 26292050 to M.M.). P.C.S. was supported through the auspices of H. Robert Horvitz, an Investigator at the Howard Hughes Medical Institute in the Department of Biology at the Massachusetts Institute of Technology. AriSLA cofinanced with support of {"}5 ? 1000{"} Healthcare Research of the Ministry of Health (grant NOVALS 2012 to N.T., CT., C.G., V.S., and J.E.L.) and the Italian Ministry of Health (grant GR-2011-02347820-IRisALS to N.T. and C.T). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. Funding was provided by the NIH/NINDS (R01NS073873 to J.E.L.), the American ALSA, and Project MinE. Funding was also provided by Instituto de Salud Carlos III (grant PI14/00088) and FUNDELA (Spanish foundation for the development of ALS research). The work leading up to this publication was funded by the European Community's Health Seventh Framework Programme (FP7/2007-2013; grant agreement number 259867). Samples used in this research were, in part, obtained from the U.K. National DNA Bank for Motor Neuron Disease (MND) Research, funded by the MND Association and the Wellcome Trust. Publisher Copyright: {\textcopyright} The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science.",
year = "2017",
month = may,
day = "3",
doi = "10.1126/scitranslmed.aad9157",
language = "English",
volume = "9",
journal = "Science translational medicine",
issn = "1946-6234",
publisher = "American Association for the Advancement of Science",
number = "388",
}